77 related articles for article (PubMed ID: 8845301)
1. Oral keratinocytes immortalized with the early region of human papillomavirus type 16 show elevated expression of interleukin 6, which acts as an autocrine growth factor for the derived T103C cell line.
Bryan D; Sexton CJ; Williams D; Leigh IM; McKay IA
Cell Growth Differ; 1995 Oct; 6(10):1245-50. PubMed ID: 8845301
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro.
Iglesias M; Plowman GD; Woodworth CD
Am J Pathol; 1995 Apr; 146(4):944-52. PubMed ID: 7717461
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7.
Woods KV; Adler-Storthz K; Clayman GL; Francis GM; Grimm EA
Cancer Res; 1998 Jul; 58(14):3142-9. PubMed ID: 9679982
[TBL] [Abstract][Full Text] [Related]
4. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.
Woodworth CD; Simpson S
Am J Pathol; 1993 May; 142(5):1544-55. PubMed ID: 8098584
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
[TBL] [Abstract][Full Text] [Related]
7. Re-expression of interleukin 1 in human papillomavirus 18 immortalized keratinocytes inhibits their tumorigenicity in nude mice.
Merrick DT; Winberg G; McDougall JK
Cell Growth Differ; 1996 Dec; 7(12):1661-9. PubMed ID: 8959334
[TBL] [Abstract][Full Text] [Related]
8. Malignant human papillomavirus type 16-transformed human keratinocytes exhibit altered expression of extracellular matrix glycoproteins.
Sheibani N; Rhim JS; Allen-Hoffmann BL
Cancer Res; 1991 Nov; 51(21):5967-75. PubMed ID: 1657375
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L
Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611
[TBL] [Abstract][Full Text] [Related]
12. Assessment of TGF-beta1-mediated growth inhibition of HPV-16- and HPV-18-transfected foreskin keratinocytes during and following immortalization.
Nindl I; Steenbergen RD; Schurek JO; Meijer CJ; van der Valk P; Snijders PJ
Arch Dermatol Res; 2003 Dec; 295(7):297-304. PubMed ID: 14576954
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
Mistry N; Simonsson M; Evander M
Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
16. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
17. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
Parker JN; Zhao W; Askins KJ; Broker TR; Chow LT
Cell Growth Differ; 1997 Jul; 8(7):751-62. PubMed ID: 9218869
[TBL] [Abstract][Full Text] [Related]
18. Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes.
Spartz H; Lehr E; Zhang B; Roman A; Brown DR
Virology; 2005 May; 336(1):11-25. PubMed ID: 15866067
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
Wilding J; Vousden KH; Soutter WP; McCrea PD; Del Buono R; Pignatelli M
Cancer Res; 1996 Nov; 56(22):5285-92. PubMed ID: 8912870
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
